Effect of antiplatelet and anticoagulation therapies on stroke risk after cervical artery dissection


  • Following carotid or vertebral artery dissection, the risk of recurrent stroke at 1 year was low, with no significant differences reported between antiplatelet (AP) and anticoagulant (AC) therapies.

Why this matters

  • To the authors’ knowledge, this is the first randomized, controlled trial analyzing treatment of carotid and vertebral dissection with complete follow-up to 1 year, thus providing robust data on which to guide therapy in this disease.